Operating cash flow increased 36.0%
Operating cash flow changed +36.0% from the comparable as-filed period.
$246.1M→$334.5M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DOCU financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 80.3%
Operating income changed +80.3% from the comparable as-filed period.
$65.2M→$117.6M2 prior comparisons
Free-cash-flow proxy increased 35.9%
Free-cash-flow proxy changed +35.9% from the comparable as-filed period.
$217.6M→$295.8M3 prior comparisons
Operating margin moved 528 bp higher
Operating margin changed +528 basis points from the comparable as-filed period.
8.15%→13.43%2 prior comparisons
Shares outstanding decreased 7.1%
Shares outstanding changed -7.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
201,104,117→186,902,4528 prior comparisons
Working capital / assets moved 620 bp lower
Working capital / assets changed -620 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
-11.58%→-17.78%4 prior comparisons
Working capital decreased 53.9%
Working capital changed -53.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$457.4M→-$704.1M4 prior comparisons
SBC / revenue moved 308 bp lower
SBC / revenue changed -308 basis points from the comparable as-filed period.
20.05%→16.97%2 prior comparisons
Current liabilities increased 11.1%
Current liabilities changed +11.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.8B→$2.0B4 prior comparisons
Capital expenditure increased 36.5%
Capital expenditure changed +36.5% from the comparable as-filed period.
$28.4M→$38.8M3 prior comparisons
Net income increased 23.4%
Net income changed +23.4% from the comparable as-filed period.
$63.0M→$77.7M2 prior comparisons
Revenue increased 9.4%
Revenue changed +9.4% from the comparable as-filed period.
$800.6M→$875.7M2 prior comparisons
R&D / revenue moved 251 bp lower
R&D / revenue changed -251 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
21.19%→18.68%2 prior comparisons
Operating cash-flow margin moved 747 bp higher
Operating cash-flow margin changed +747 basis points from the comparable as-filed period.
30.73%→38.20%2 prior comparisons
Free-cash-flow margin moved 659 bp higher
Free-cash-flow margin changed +659 basis points from the comparable as-filed period.
27.18%→33.77%2 prior comparisons
Cash & equivalents decreased 12.0%
Cash & equivalents changed -12.0% from the comparable as-filed period.
$600.0M→$528.2M3 prior comparisons
Gross margin moved 36 bp higher
Gross margin changed +36 basis points from the comparable as-filed period.
79.33%→79.69%2 prior comparisons
Gross profit increased 9.9%
Gross profit changed +9.9% from the comparable as-filed period.
$635.2M→$697.9M2 prior comparisons
Capex / revenue moved 88 bp higher
Capex / revenue changed +88 basis points from the comparable as-filed period.
3.55%→4.43%2 prior comparisons
Receivables / revenue moved 227 bp lower
Receivables / revenue changed -227 basis points from the comparable as-filed period.
44.58%→42.31%2 prior comparisons
Trade receivables increased 3.8%
Trade receivables changed +3.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$356.9M→$370.5M4 prior comparisons
Current ratio decreased 13.4%
Current ratio changed -13.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
0.74→0.644 prior comparisons
Research & development decreased 3.6%
Research & development changed -3.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$169.6M→$163.6M2 prior comparisons
Current assets decreased 3.8%
Current assets changed -3.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.3B→$1.3B4 prior comparisons
Stock-based compensation decreased 7.4%
Stock-based compensation changed -7.4% from the comparable as-filed period.
$160.5M→$148.6M3 prior comparisons
Operating cash flow / net income increased 10.2%
Operating cash flow / net income changed +10.2% from the comparable as-filed period.
3.91→4.32 prior comparisons
Total assets increased 0.3%
Total assets changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.9B→$4.0B4 prior comparisons
Free-cash-flow proxy increased 27.0%
Free-cash-flow proxy changed +27.0% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
$227.8M→$289.4M6 prior comparisons
Operating cash flow increased 27.9%
Operating cash flow changed +27.9% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
$251.4M→$321.7M6 prior comparisons
Capital expenditure increased 36.5%
Capital expenditure changed +36.5% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
$23.6M→$32.3M6 prior comparisons
Operating income increased 84.7%
Operating income changed +84.7% from the comparable as-filed period.
$60.3M→$111.3M3 prior comparisons
Operating margin moved 552 bp higher
Operating margin changed +552 basis points from the comparable as-filed period.
7.89%→13.41%3 prior comparisons
Cash & equivalents decreased 16.6%
Cash & equivalents changed -16.6% from the comparable as-filed period.
$657.4M→$548.0M2 prior comparisons
Revenue increased 8.7%
Revenue changed +8.7% from the comparable as-filed period.
$763.7M→$830.2M3 prior comparisons
SBC / revenue moved 204 bp lower
SBC / revenue changed -204 basis points from the comparable as-filed period.
19.07%→17.03%2 prior comparisons
Gross profit increased 8.7%
Gross profit changed +8.7% from the comparable as-filed period.
$606.4M→$659.0M3 prior comparisons
Capex / revenue moved 79 bp higher
Capex / revenue changed +79 basis points from the comparable as-filed period.
3.09%→3.88%2 prior comparisons
Gross margin moved 3 bp lower
Gross margin changed -3 basis points from the comparable as-filed period.
79.41%→79.37%3 prior comparisons
Net income increased 8.5%
Net income changed +8.5% from the comparable as-filed period.
$72.1M→$78.2M3 prior comparisons
Stock-based compensation decreased 2.9%
Stock-based compensation changed -2.9% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
$145.6M→$141.4M6 prior comparisons
Research & development increased 0.1%
Research & development changed +0.1% from the comparable as-filed period.
$159.4M→$159.6M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.